Accueil   Diary - News   All news ImmunID Signs Master Collaboration Agreement with MSK

ImmunID Signs Master Collaboration Agreement with MSK

 ImmunID, the immune companion diagnostics for precision medicine company, today announces that it has just signed a master collaboration agreement with Memorial Sloan Kettering Cancer Center (MSK) in New York, United States. MSK is the world’s oldest and largest private cancer center. It has ranked as one of the top two hospitals for cancer care in the United States for more than 25 years.


Read the press release